MedTrace Logo

Remission Induction and Sustenance in Graves' Disease 2

NCT00796913 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2019-01-10

No results posted yet for this study

Summary

ATD therapy for Graves' disease is one of the commonly used options for therapy of the hyperthyroidism. The investigators study how to optimally keep patients in remission.

Conditions

  • Graves Disease
  • Hyperthyroidism

Interventions

OTHER

Stop medication

Stop medication Stop medication + se supplement

Sponsors & Collaborators

  • Aalborg University Hospital

    lead OTHER

Principal Investigators

  • Jesper S Karmisholt, MD, Ph.D · Aalborg University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-07
Primary Completion
2015-05-15
Completion
2015-05-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00796913 on ClinicalTrials.gov